BAUDAX BIO INC (BXRX) Forecast, Price Target & Analyst Ratings

NASDAQ:BXRX • US07160F4046

Current stock price

0.1864 USD
+0 (+0.59%)
At close:
0.17 USD
-0.02 (-8.8%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BAUDAX BIO INC (BXRX).

Forecast Snapshot

Consensus Price Target

Price Target
$24.48
+ 13,033.05% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 21, 2024
Period
Q3 / 2023
EPS Estimate
-$0.54
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$24.48
Upside
+ 13,033.05%
From current price of $0.19 to mean target of $24.48, Based on 6 analyst forecasts
Low
$24.24
Median
$24.48
High
$25.20

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for BXRX. The average price target is 24.48 USD. This implies a price increase of 13033.05% is expected in the next year compared to the current price of 0.1864.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BXRX Current Analyst RatingBXRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

BXRX Historical Analyst RatingsBXRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
BXRX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BXRX.
In the previous month the buy percentage consensus was at a similar level.
BXRX was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-01-03Noble Capital MarketsDowngrade Outperform -> Market Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 21, 2024
Period
Q3 / 2023
EPS Estimate
-$0.54
Revenue Estimate
Revenue Q2Q
-100.00%
EPS Q2Q
97.95%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
42.39%

Next Earnings Summary

BXRX is expected to report earnings on 2/21/2024. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
BXRX revenue by date.BXRX revenue by date.
490K1.08M
120.41%		1.27M
17.59%
-100.00%		33.66M93.84M
178.79%
EBITDA
YoY % growth
BXRX ebitda by date.BXRX ebitda by date.
-72.23M
-125.44%		-16.19M
77.59%		-30.8M
-90.24%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
BXRX ebit by date.BXRX ebit by date.
-74.79M
-129.98%		-19.01M
74.58%		-32.97M
-73.44%		-21.454M
34.93%		-21.42M
0.16%		-21.93M
-2.38%		-2.091M
90.47%		34.272M
1,739.02%
Operating Margin
BXRX operating margin by date.BXRX operating margin by date.
-15,263.27%-1,760.19%-2,596.06%N/AN/AN/A-6.21%36.52%
EPS
YoY % growth
BXRX eps by date.BXRX eps by date.
-7,728.00
-47.86%		-578.80
92.51%		-207.53
64.14%		-1.68
99.19%		-0.38
77.58%		-0.33
13.51%		-0.05
84.38%		0.44
960.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.54
97.95%		-0.12
99.01%		-0.12
96.87%		-0.09
93.96%		-0.09
83.02%		-0.08
33.33%
Revenue
Q2Q % growth
-100.00%
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.692M
35.64%		-4.794M
22.30%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BXRX Yearly Revenue VS EstimatesBXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2026 2027 20M 40M 60M 80M
BXRX Yearly EPS VS EstimatesBXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2K -4K -6K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.96%
EPS Next 5 Year
14.89%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
149.06%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BAUDAX BIO INC / BXRX Forecast FAQ

What is the average price target for BAUDAX BIO INC (BXRX) stock?

6 analysts have analysed BXRX and the average price target is 24.48 USD. This implies a price increase of 13033.05% is expected in the next year compared to the current price of 0.1864.

What is the next earnings date for BXRX stock?

BAUDAX BIO INC (BXRX) will report earnings on 2024-02-21, after the market close.

Can you provide the consensus estimates for BAUDAX BIO INC next earnings?

The consensus EPS estimate for the next earnings of BAUDAX BIO INC (BXRX) is -0.54 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed BAUDAX BIO INC (BXRX)?

The number of analysts covering BAUDAX BIO INC (BXRX) is 6.